Details for Australian Trade Mark No. 1205063 (hide)

Owner Merck Sharp & Dohme Corp.

Convention US 5 March 2007 77121905

IR Number 938147

Various Convention priority claimed: 5 March 2007, United States of America, No. 77121905 in respect of CLASS: 05 PHARMACEUTICAL PREPARATIONSFOR THE TREATMENT OF ADDICTION, URINARY INCONTINENCE, DIABETES, CARDIOVASCULAR DISEASES AND DISORDERS, CEREBROVASCULAR DIS

Filing Date 9 July 2007

Classes

Class 5 Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculo-skeletal disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, antiemetic preparations, and vaccine preparations

Event Publications

8 November 2007 Application filed

29 November 2007 Application Accepted

3 April 2008 Trade Mark Registered/Protected

1 April 2010 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1205064

1205062-HAMLET